Director Thomas Lehrman Sells $2.36M in Open Market Shares
IBTA sits 75% above its 52-week low of $19.1.
Summary
Ibotta Director Thomas D. Lehrman sold $2.36 million worth of company stock in open market transactions, reducing his total holdings.
Key Events · Ownership and Investor Activity · IBTA
-
Director Sells Shares
Thomas D. Lehrman, a Director at Ibotta, Inc., sold 75,907 shares of Class A Common Stock in multiple open market transactions between May 15 and May 18, 2026.
-
Significant Transaction Value
The total value of the shares sold amounted to $2,362,947, representing a substantial disposition of his stake.
-
Follows Prior Intent to Sell
This Form 4 filing confirms actual sales following a Form 144 filed on May 12, 2026, by the same director, which indicated an intent to sell shares.
-
Reduced Holdings
Post-transaction, Lehrman's total holdings in Ibotta, Inc. are reduced to 63,166 shares.
Analysis · IBTA · Trade & Services
Director Thomas D. Lehrman executed a significant open market sale of Ibotta shares totaling $2.36 million. This transaction follows a recent Form 144 filing by the same director, indicating an intent to sell, and now confirms the actual disposition of a substantial portion of his holdings. This sale represents a notable reduction in a director's stake, which can be interpreted as a negative signal regarding future prospects, especially given the company's recent mixed financial results and ongoing share repurchase program.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IBTA was trading at $33.40 on NYSE in the Trade & Services sector, with a market capitalization of approximately $796.4M. The 52-week trading range was $19.10 to $56.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.